Sean Saint

And I'll specifically state for the user experience.

And I hope that everything Betabionics does today and ever is all about, you know, is in service of a better user experience.

With a two-part architecture, what we're able to do

is number one eliminate any kind of recharging or any of that with the product because you get fresh batteries every time we eliminate any interaction with the phone required when we're changing the product because when you separate the two components and put them back together again you know it already knows that that's happening because it's connecting and disconnecting to the batteries you're eliminating any bluetooth pairing that has to happen because the reusable component

is already paired to that phone.

That eliminates a step.

And of course, it has cost of goods advantages as well, but that's not the primary reason that we do it.

We do it for user experience reasons.

Certainly it does.

And maybe, I guess, is the answer.

Yeah, it's a great point.

The reusable component is going to continue.

It remembers previous sessions, if you will.

So it continues, just evolves, gets better and better and better over every day.

Doesn't take any longer to adapt than the Islet did.

It'll be the same algorithm based experience.

And there are multiple ways to design patch pump experiences, some that it's patch specific, some that it's not.

I really can't comment into what, what our, you know, others have done, but yeah, that's, that's an option.

That's a great question.

You know, the agency did us this huge favor a number of years ago when they came up with the concepts of ICGM, which are the requirements that a CGM has to meet to be part of an AID system, IAGC, which is the algorithm, and ACE, which is the pump itself.